bpc 157 oral administration studies BPC-157 (500mcg) Multifunctionality and Possible Medical Application

Poster Session II - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P1017 - ESOC25-519 VAGOTOMY AND RISK OF STROKE COMPARED WITH MATCHED GENERAL POPULATION: A POPULATION-BASED COHORT STUDY Oscar Rosenkrantz 1 , Pter Szentkti 1 , Nils Skajaa 2 , Dvid Nagy 1 , Erzsbet Horvth-Puh 1 , Holly Elser 1,3,4 , Cecilia Hvitfeldt Fuglsang 1 , Henrik Toft Srensen 1 1 Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark, 2 Novo Nordisk A/S, Sborg, Denmark, 3 Department of Neurology, University of Pennsylvania, Philadelphia, United States, 4 Center for Population Health Sciences, Stanford University, Palo Alto, United States Background and Aims: Vagotomy, used to treat refractory peptic ulcers decades ago, has been associated with reduced risk of selected neurological diseases, possibly by disrupting axonal transport of microbial organisms or misfolded proteins via the vagus nerve to the brain

BPC-157 has also been found to guard against stomach ulcers, decrease inflammation in the gut, and enhance gut health

Pain Relief Some anecdotal reports suggest that BPC 157 may help reduce stiffness, soreness, or pain during recovery

Please call the Pharmacy 777 location - Opens in new tab you made your booking with and our team can help you rebook

Cochrane review shows modest but real benefit for some patients